Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of nano-microsphere formed based on host-guest interaction and its preparation method and application

A nano-microsphere, host-guest technology, which is applied in the direction of non-active ingredients of polymer compounds, anti-tumor drugs, block delivery, etc., can solve the problem of low solubility, achieve good biocompatibility, good drug sustained release function, The effect of structural stability

Active Publication Date: 2018-02-23
NANJING UNIV
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, similar to paclitaxel, cabazitaxel has a very low solubility in water. How to prepare stable and effective cabazitaxel preparations is the goal of future research.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of nano-microsphere formed based on host-guest interaction and its preparation method and application
  • A kind of nano-microsphere formed based on host-guest interaction and its preparation method and application
  • A kind of nano-microsphere formed based on host-guest interaction and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1: Using amantadine as an initiator to initiate the polymerization of ε-caprolactone

[0025] Under the protection of argon, 30 mg amantadine, 2.2 mL ε-caprolactone, and 10 uL stannous octoate were added into a 25 mL round bottom flask, and the mixture was stirred and reacted at 120° C. for 48 hours. After the reaction, cool to room temperature, add 10 mL of dichloromethane to dissolve the reaction product, and then precipitate in 200 mL of anhydrous ether to obtain a white solid product, dry it in vacuum, and obtain the product amantadine as the initiator to initiate the polymerization of ε-caprolactone, labeled For: ada-PCL. The molecular weight was determined to be 9803 g / mol by size exclusion chromatography. 1 HNMR (400MHz, CDCl 3 ,δ): 1.41(m,2H), 1.67(m,4H), 1.99(s,adamantyl), 2.07(s,adamantyl), 2.32(t,2H), 4.08(t,2H).

Embodiment 2

[0026] Example 2: Using amantadine as an initiator to initiate the polymerization of ε-caprolactone

[0027] Under argon protection, 30 mg amantadine, 1 mL ε-caprolactone, and 10 uL stannous octoate were added into a 25 mL round bottom flask, and the mixture was stirred and reacted at 120° C. for 48 hours. After the reaction, cool to room temperature, add 10 mL of dichloromethane to dissolve the reaction product, and then precipitate in 200 mL of anhydrous ether to obtain a white solid product, dry it in vacuum, and obtain the product amantadine as the initiator to initiate the polymerization of ε-caprolactone, labeled For: ada-PCL. The molecular weight was determined to be 3945 g / mol by size exclusion chromatography.1 H NMR (400MHz, CDCl 3 ,δ): 1.41(m,2H), 1.67(m,4H), 1.99(s,adamantyl), 2.07(s,adamantyl), 2.32(t,2H), 4.08(t,2H).

Embodiment 3

[0028] Example 3: Using amantadine as an initiator to initiate the polymerization of D, L-lactide

[0029] Add 15mL of anhydrous toluene, 30mg of amantadine, and 2g of D,L-lactide into a 50mL round-bottomed flask under the protection of argon, then add 10uL of stannous octoate, and stir at 120°C for 48 hours. Add 10mL of dichloromethane to dilute the solution, then precipitate the product in 300mL of methanol, and then dissolve the white solid in 10mL of acetone, precipitate it in 200mL of water to obtain a white solid, and dry the resulting solid in vacuum to obtain amantadine as an initiator to initiate polymerization D. L-lactide, labeled: ada-PDLLA. The molecular weight was determined to be 9764 g / mol by size exclusion chromatography. 1 H NMR (400MHz, CDCl 3 ,δ): 1.58 (m, 3H), 1.99 (s, adamantyl), 2.07 (s, adamantyl), 5.21 (m, 1H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to View More

Abstract

A poly(ε-caprolactone or poly-D,L-lactide) with an adamantane terminal group as the hydrophobic core, and multiple polyvinylpyrrolidone macromolecular chains modified with multiple hydroxyl groups on the 6-position C of glucose ‑Cyclodextrin is a hydrophilic part, and it is a nanoparticle formed by the interaction between adamantane and β‑cyclodextrin host and guest. Its characteristics are: its surface is hydrophilic polyvinylpyrrolidone, and its interior is hydrophobic polyε‑caprolactone or polyD,L‑lactide, and the two parts pass through the host and object of adamantane and β‑cyclodextrin role connection. Poly(ε-caprolactone) or poly(D,L-lactide) linked with adamantane has a molecular weight of 2,000 to 10,000 g / mol, and β-cyclodextrin can modify multiple polyvinylpyrrolidones, and the molecular weight of each polyvinylpyrrolidone It is 1000~10000g / mol. The particle size distribution of the nano microspheres is 40-200nm. The nanometer microsphere of the invention has good biocompatibility and stability, can be used as a drug carrier, and has a slow-release effect, and the invention discloses its method and application.

Description

technical field [0001] The invention relates to a non-toxic and biodegradable nanometer particle formed based on host-guest interaction, which can be used as a carrier of drug cabazitaxel. Background technique [0002] Cabazitaxel, a derivative of paclitaxel, is a microtubule-inhibiting drug that was approved by the US FDA in 2010 as a drug for the treatment of patients with metastatic hormone-refractory prostate cancer. In vitro experiments, cabazitaxel has a killing effect on various tumor cells in mice and humans, and the anticancer activity of cabazitaxel is also higher than that of docetaxel for a variety of drug-resistant cell lines. Cabazitaxel has a low affinity with P-glycoprotein (P-gp) 1, so it has a certain lethality to drug-resistant cells, and this drug is easy to pass through the blood-brain barrier. It is a new anticancer drug with development prospects . However, similar to paclitaxel, cabazitaxel has a very low solubility in water. How to prepare a stable...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/16A61K31/337A61K47/40A61P35/00
Inventor 蒋锡群谢晨张鹏
Owner NANJING UNIV